V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 260009841 | 260006275 | 1.71 | 101.8 | Disease modification (D) | 2017-11-05 | 2017-11-05 | Hydroxycarbamide | 01 | N | 260010612 | ABVD R |
| 260009842 | 260006275 | 1.83 | 81.8 | Disease modification (D) | 2018-12-01 | 2018-12-01 | CISPLATIN + ETOPOSIDE | 02 | N | 260010612 | CISPLATIN + ETOPOSIDE |
| 260009843 | 260006275 | 1.67 | 68 | null | 2015-09-30 | 2015-09-30 | BLEOMYCIN + CISPLATIN + VINCRISTINE | 02 | null | 260010612 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE |
| 260009844 | 260006276 | 1.6 | 0 | Palliative (P) | 2014-10-16 | 2014-10-23 | GEMCARBO | 2 | null | 260010629 | CARBOPLATIN + PACLITAXEL |
| 260009845 | 260012395 | null | 75 | Curative (C) | 2018-04-24 | 2018-05-01 | Rituximab | N | N | 260010646 | RITUXIMAB |
| 260009846 | 260006277 | 1.79 | null | Adjuvant (A) | 2015-04-02 | 2015-04-02 | Cisplatin + Etoposide (5 day) | N | N | 260010651 | CARBOPLATIN + ETOPOSIDE |
| 260009847 | 260006277 | 1.81 | null | null | 2018-09-11 | 2018-09-12 | 111 Trial (formerly BEP 111) | 02 | N | 260010651 | DOXORUBICIN |
| 260009848 | 260006278 | 1.66 | 57 | Not known (9) | 2017-09-23 | 2017-09-28 | CISPLATIN + ETOPOSIDE | 02 | null | 260010674 | EP |
| 260009849 | 260006279 | 0 | 92.8 | Curative (C) | 2016-12-22 | 2016-12-23 | CARBOPLATIN + GEMCITABINE | N | N | 260010693 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 260009850 | 260012397 | null | 95 | Disease modification (D) | 2015-12-20 | 2016-01-03 | Doxorubicin + Ifosfamide | 02 | N | 260010715 | CISPLATIN + ETOPOSIDE |
| 260009851 | 260015701 | 1.73 | null | Palliative (P) | null | 2018-08-31 | BLEOMYCIN + CISPLATIN + VINCRISTINE | null | null | 260010719 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + ETOPOSIDE + VINCRISTINE |
| 260009852 | 260015701 | 1.77 | 81.6 | Adjuvant (A) | 2016-02-03 | 2016-02-18 | Cisplatin + Etoposide (3 day) | N | N | 260010719 | CISPLATIN + ETOPOSIDE |
| 260009853 | 260006280 | 1.8 | 56.3 | Palliative (P) | 2015-04-12 | 2015-04-13 | EP | 02 | Y | 260010734 | CISPLATIN + ETOPOSIDE |
| 260009854 | 260006281 | 1.62 | 75 | Curative (C) | 2015-07-08 | 2015-07-09 | Bendamustine +/- Prednisolone | N | N | 260010757 | CARBOPLATIN + PACLITAXEL |
| 260009855 | 260006282 | 1.72 | null | Disease modification (D) | 2013-05-30 | 2013-05-30 | Cisplatin + Etoposide (3 day) | N | N | 260010806 | CISPLATIN |
| 260009856 | 260006282 | 1.67 | 115 | Curative (C) | 2015-06-09 | 2015-06-14 | Chlorambucil + Pred + Rituximab | N | N | 260010806 | EP |
| 260009857 | 260006283 | null | 57 | Curative (C) | 2015-04-19 | 2015-04-19 | Carboplatin + Etoposide IV 3 day | N | N | 260010826 | RITUXIMAB |
| 260009858 | 260006283 | 1.69 | 86 | Palliative (P) | 2014-05-25 | 2014-05-26 | Carboplatin + Vinorelbine Oral | 01 | N | 260010826 | CISPLATIN + IFOSFAMIDE + VINBLASTINE |
| 260009859 | 260006283 | 1.83 | 75 | Disease modification (D) | 2018-10-28 | 2018-11-20 | Carboplatin + Pemetrexed | N | N | 260010826 | CARBOPLATIN + VINORELBINE |
| 260009860 | 260006283 | 1.6 | 76 | Palliative (P) | null | 2018-03-21 | FEC 60 or 75 | null | null | 260010826 | BENDAMUSTINE |
| 260009861 | 260006284 | 0 | 87.5 | Curative (C) | 2015-12-09 | 2015-12-09 | Cisplatin + Etoposide (5 day) | 99 | null | 260010857 | NOT MATCHED |
| 260009862 | 260006284 | null | null | Curative (C) | 2019-02-12 | 2019-02-27 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE | N | N | 260010857 | EVEROLIMUS |
| 260009863 | 260006284 | 1.77 | 83 | Adjuvant (A) | 2016-07-14 | 2016-08-07 | Cisplatin + Etoposide (5 day) | N | 2 | 260010857 | CISPLATIN + ETOPOSIDE |
| 260009864 | 260006285 | 1.57 | null | Curative (C) | 2016-12-27 | 2017-02-07 | Rituximab | N | N | 260010929 | RITUXIMAB |
| 260009865 | 260006285 | 1.57 | 85 | Curative (C) | 2016-05-28 | 2016-07-04 | Rituximab (Maintenance) | N | N | 260010929 | BENDAMUSTINE |
| 260009866 | 260006286 | null | 64.3 | Curative (C) | null | 2016-11-26 | Rituximab (Maintenance) | null | null | 260010963 | CARBOPLATIN + VINORELBINE |
| 260009867 | 260006286 | 1.83 | 134.5 | Curative (C) | 2015-08-07 | 2015-08-08 | CISPLATIN + ETOPOSIDE | N | N | 260010963 | CISPLATIN + ETOPOSIDE |
| 260009868 | 260006287 | 1.61 | null | Palliative (P) | 2014-01-06 | 2014-01-19 | CISPLATIN + IFOSFAMIDE + VINBLASTINE | N | N | 260010981 | CISPLATIN + ETOPOSIDE |
| 260009869 | 260006287 | 1.6 | 84.2 | Adjuvant (A) | 2018-06-25 | 2018-08-13 | Carboplatin + Paclitaxel (3 weekly) | 2 | N | 260010981 | GALLIUM TRIAL |
| 260009870 | 260006287 | 1.74 | 88 | Not known (9) | 2017-06-17 | 2017-06-18 | Carboplatin + Etoposide IV 3 day | N | null | 260010981 | CISPLATIN + ETOPOSIDE |
| 260009871 | 260006288 | 1.73 | 96 | null | 2017-03-09 | 2017-03-12 | BLEOMYCIN + CARBOPLATIN + ETOPOSIDE | 01 | null | 260011099 | BLEOMYCIN + CISPLATIN + ETOPOSIDE |
| 260009872 | 260006289 | 1.7 | 57 | Neo-adjuvant (N) | 2016-03-08 | 2016-03-29 | Carboplatin + Etoposide IV 3 day | 02 | N | 260011149 | BLEOMYCIN + CISPLATIN + VINBLASTINE |
| 260009873 | 260006289 | 1.88 | 80.3 | Curative (C) | 2014-12-03 | 2014-12-15 | CISPLATIN + ETOPOSIDE | 2 | null | 260011149 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE |
| 260009874 | 260006290 | 1.55 | 74.7 | Curative (C) | 2014-04-30 | 2014-05-10 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | 260011239 | CARBOPLATIN + ETOPOSIDE |
| 260009875 | 260006290 | 1.85 | null | Palliative (P) | 2015-12-20 | 2015-12-22 | TIP | 02 | N | 260011239 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE |
| 260009876 | 260006291 | 1.85 | 93.5 | Curative (C) | 2016-09-21 | 2016-09-21 | EP 1 2 or 3 day | 02 | N | 260011287 | CISPLATIN + ETOPOSIDE |
| 260009877 | 260006292 | 1.64 | 69.9 | Curative (C) | 2013-05-22 | 2013-05-24 | Rituximab (SUBCUTANEOUS Maintenance) | N | N | 260011330 | CISPLATIN + ETOPOSIDE |
| 260009878 | 260012406 | 1.82 | 106.4 | Curative (C) | 2017-11-18 | 2017-11-21 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + ETOPOSIDE + VINCRISTINE | 02 | N | 260011332 | CISPLATIN + ETOPOSIDE |
| 260009879 | 260006293 | 1.65 | 83 | Adjuvant (A) | 2018-06-09 | 2018-06-10 | TIP | 2 | N | 260011343 | EP |
| 260009880 | 260006293 | 1.77 | 84 | null | 2018-01-10 | 2018-02-07 | Sunitinib | 02 | N | 260011343 | CISPLATIN + ETOPOSIDE |
| 260009881 | 260006293 | null | 91 | null | null | 2014-12-14 | BLEOMYCIN + CISPLATIN + ETOPOSIDE | null | null | 260011343 | PEMBROLIZUMAB |
| 260009882 | 260006294 | null | 73.05 | Disease modification (D) | 2015-11-06 | 2015-11-07 | CISPLATIN + RT | Y | N | 260011404 | RITUXIMAB |
| 260009883 | 260012408 | 1.64 | null | Palliative (P) | 2014-08-08 | 2014-08-10 | Bleomycin + Cisplatin + Vinblastine | N | N | 260011412 | TIP |
| 260009884 | 260012408 | 1.54 | 86.9 | Palliative (P) | 2014-08-01 | 2014-08-16 | Rituximab | N | N | 260011412 | CISPLATIN + RT |
| 260009885 | 260012408 | 1.83 | 98.3 | Curative (C) | 2016-11-01 | 2016-11-06 | CHLORAMBUCIL + OBINUTUZUMAB | N | N | 260011412 | BLEOMYCIN + CISPLATIN + ETOPOSIDE |
| 260009886 | 260012408 | 1.69 | 88.8 | null | 2018-06-18 | 2018-06-21 | CISPLATIN + ETOPOSIDE | 02 | null | 260011412 | ETOPOSIDE |
| 260009887 | 260006295 | 1.62 | 66.3 | Curative (C) | 2016-08-03 | 2016-08-09 | R Chlorambucil | 02 | N | 260011453 | CARBOPLATIN + VINORELBINE |
| 260009888 | 260006295 | 1.74 | 72 | Curative (C) | null | 2018-08-22 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | N | N | 260011453 | CISPLATIN + ETOPOSIDE |
| 260009889 | 260006296 | 1.9 | 66.7 | Palliative (P) | 2018-10-05 | 2019-05-25 | Cisplatin + Etoposide (5 day) | N | N | 260011489 | BLEOMYCIN + CISPLATIN + ETOPOSIDE |
| 260009890 | 260006296 | 1.84 | 107 | Curative (C) | 2015-06-09 | 2015-06-14 | CISPLATIN + VINORELBINE | 01 | N | 260011489 | BLEOMYCIN + CISPLATIN + ETOPOSIDE |